Observational Study “Choroideremie, keine Medikation”

Observed Drugs

Title of the Observational Study

NSR-CHM-OS1: Natural History of the Progression of Choroideremia Study

Registered on
06/09/2015
Start date
06/10/2015
End date
06/10/2016
Executing company
Chiltern international GMBH
Sponsor
NightstaRx Ltd
Number of Docs1
2
Number of Patients2
20
Payment per Patient3
6894.40 €
Fee details
4 Visiten

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.